Physician profile
Stanley Thornton
NPI 1134149412
$1,018.91
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $36.73 · 2021: $223 · 2022: $38.21 · 2023: $141 · 2024: $51.45 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463 · Education: $5.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.67 |
| Education | $5.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $254.69 | 2019-2025 | Bridion |
| Heron Therapeutics, INC. | $200.05 | 2021-2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $183.88 | 2019-2025 | Exparel |
| Mallinckrodt Enterprises LLC | $120.39 | 2019 | |
| Philips North America LLC | $107.27 | 2025 | Zenition 90 M |
| Acacia Pharma INC | $62.46 | 2021 | |
| Mallinckrodt Hospital Products INC. | $30.46 | 2020-2021 | |
| Covidien LP | $20.10 | 2020 | |
| Medtronic, INC. | $19.99 | 2024 | Invos |
| Edwards Lifesciences Corporation | $19.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.